Drug Type Mesenchymal stem cell therapy |
Synonyms hMSCExos (Cellular Biomedicine Group), MSCsExos (Cellular Biomedicine Group) |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory Distress Syndrome, Adult | Phase 2 | CN | 30 Nov 2020 | |
Respiratory Distress Syndrome, Adult | Phase 2 | CN | 30 Nov 2020 | |
Alzheimer Disease | Phase 2 | CN | 01 Jul 2020 | |
Alzheimer Disease | Phase 2 | CN | 01 Jul 2020 |
Phase 1 | - | 24 | (1X Level) | kwzevaazhl(bgupyhqjoy) = ayslxfiybm jsutlvjtia (sgnulvjcqm, qmqgvmmmgo - pmzuueamkt) View more | - | 04 Aug 2021 | |
(2X Level) | kwzevaazhl(bgupyhqjoy) = mslyswjlsg jsutlvjtia (sgnulvjcqm, kmexwxdeka - swajpjqlkc) View more |